Çiğdem Damla DENİZ, Gülsüm GÖNÜLALAN, Kübra SAYIN, Betül KOZANHAN

Relationship of zonulin levels with thyroid function and metabolic parameters in Hashimoto’s Thyroiditis

Aim: Intestinal permeability is one of the factors responsible for the pathogenesis of many immune-related diseases, one of which is Hashimoto’s-thyroid (HT). We used zonulin as a biomarker of intestinal permeability in this cross-sectional study. We aimed to determine serum zonulin levels in individuals diagnosed with HT and to investigate the relationship between zonulin and autoimmunity biomarkers, thyroid function and metabolic parameters. Materials and Methods: The study was conducted with 43 women newly diagnosed with HT and a control group of 30 matched with them. The evaluated parameters were thyroperoxidase-antibody (TPO-AB), thyroglobulin-antibody (Tg-AB), thyroid hormone profile, metabolic parameters and zonulin levels. Results: Higher levels of TSH, TPO-AB, Tg-AB, TG and TC were measured in the HT group compared to controls (P < 0.005). The means of zonulin in HT.patients were significantly higher than in the control group (P < 0.005). Conclusion: The correlations between zonulin levels and TSH and TPO-AB among all subjects in this study support the idea that intestinal permeability is a distinguishing feature in the conditions causing the formation of immunological hypersensitivity in HT. More studies are needed to prove that impaired intestinal permeability is among the causes of decreased thyroid function.

PDF

___

1. Burek CL, Rose NR. Autoimmune thyroiditis and ROS. Autoimmun Rev. 2008;7(7): 530–7.
2. Orgiazzi J. Thyroid autoimmunity. Presse Med. 2012;41:611–25.
3. Fountoulakis S, Tsatsoulis A. On the pathogenesis of autoimmune thyroid disease: a unifying hypothesis. Clin Endocrinol. 2004;60(4):397–409.
4. Catureglia P, DeRemigisa A, Rosea NR. Hashimoto thyroiditis: Clinical and diagnostic criteria. Autoimmun Rev. 2014; 13: 391– 7.
5. Fasano A. Leaky Gut and Autoimmune Diseases. Clinic Rev Allerg Immunol. 2012; 42:71
6. Abreu MT. Toll-like receptor signaling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol. 2010; 10:131–44.
7. Fasano A. Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall. Am J Pathol. 2008; 173:1243–52.
8. Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol. 2009; 124:3–20
9. Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011; 91:151–75.
10. Mäkelä M, Vaarala O, Hermann R et al. Enteral virus infections in early childhood and an enhanced type 1 diabetesassociated antibody response to dietary insulin. J Autoimmun. 2006; 27:54– 61
11. Mojibian M, Chakir H, Lefebvre DE, Crookshank JA, Sonier B, Keely E, Scott FW. Diabetes-specific HLA-DR-restricted proinflammatory T-cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes. Diabetes. 2009; 58:1789–96.
12. Westall FC. Abnormal hormonal control of gut hydrolytic enzymes causes autoimmune attack on the CNS by production of immune-mimic and adjuvant molecules: a comprehensive explanation for the induction of multiple sclerosis. Med Hypotheses. 2007; 68:364–9.
13. Yokote H, Miyake S, Croxford JL, Oki S, Mizusawa H, Yamamura T. NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. Am J Pathol. 2008; 173:1714–23.
14. Edwards CJ. Commensal gut bacteria and the etiopathogenesis of rheumatoid arthritis. J Rheumatol. 2008; 35:1477–97
15. Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci USA. 2009;106:16799–804.
16. Sapone A, de Magistris L, Pietzak M, Clemente MG, Tripathi A, Cucca F, et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes. 2006;55:1443–9.
17. Moreno-Navarrete JM, Sabater M, Ortega F, Ricart W, Fernandez-Real JM. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS ONE. 2012;7:37160-8.
18. Garn H, Bahn S, Baune BT, Binder EB, Bisgaard H, Chatila TA, et al. Current concepts in chronic inflammatory diseases: interactions between microbes, cellular metabolism, and inflammation. J Allergy Clin Immunol. 2016;138:47–56.
19. Benvenga S, Guarneri F. Molecular mimicry and autoimmune thyroid disease. Rev Endocr Metab Disord. 2016;17:485–98.
20. Arata N, Ando T, Unger P, Davies TF. By-stander activation in autoimmune thyroiditis: studies on experimental autoimmune thyroiditisin the GFP+ fluorescent mouse. Clin Immunol. 2006;121:108–17.
21. de Oliveira GLV, Leite AZ, Higuchi BS, GonzagaMI, Mariano VS. Intestinal dysbiosis and probiotic applications in autoimmune diseases. Immunology. 2017;152:1–12.
22. Sapone A, Magistris L, PietzakM, Clemente MG, Tripathi A, Cucca F, Lampis R, Kryszak D, Carteni M, Generoso M, Iafusco D, Prisco F, Laghi F, Riegler G, Carratu R, Counts D, FasanoA. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes. 2006;55: 1443–49.
23. El Asmar R, Panigrahi P, Bamford P, Berti I, Not T, Coppa GV, Catassi C, Fasano A. Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology. 2002; 123.
24. Drago S, Asmar R, Pierro M, Grazia Clemente M, Tripathi A, Sapone A, Thakar M, Iacono G, Carroccio A, D’Agate C, Not T, Zampini L, Catassi C, Fasano A. Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines, Scand. J. Gastroenterol. 2006;41:408–19.
25. Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, Goldblum SE. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet. 2000; 355:1518–19.
26. Wang W, Uzzau S, Goldblum SE, FasanoA. Human zonulin, a potential modulator of intestinal tight junctions, J. Cell Sci. 2000; 113:4435–40.
27. Smecuol E, Sugai E, Niveloni S, Vazquez H, Pedreira S, Mazure R, Moreno ML, Label M, Maurino E, Fasano A, Meddings J, Bai JC. Permeability, zonulin production, and enteropathy in dermatitis herpetiformis, Clin. Gastroenterol. Hepatol. 2005;3: 335–41.
28. Sasso FC, Carbonara O, Torella R, Mezzogiorno A, Esposito V, Demagistris L. Ultrastructural changes in enterocytes in subjects with Hashimoto’s thyroiditis. Gut. 2004;53:1878–80.
29. Mu Q, Kirby J, Reilly CM, Luo XM. Leaky gut as a danger signal for autoimmune diseases. Front Immunol. 2017;8:598.
30. Ishaq HM, Mohammad IS, Guo H, Shahzad M, Hou YJ, Ma C, et al. Molecular estimation of alteration in intestinal microbial composition in Hashimoto’s thyroiditis patients. Biomed Pharmacother. 2017;95:865–74.
31. Zhao F, Feng J, Li J, Zhao L, Liu Y, Chen H, et al. Alterations of the gut microbiota in Hashimoto’s thyroiditis patients. Thyroid. 2018;28:175–86.
32. Lauritano EC, Bilotta AL, Gabrielli M, Scarpellini E, Lupascu A, Laginestra A, et al. Association between hypothyroidism and small intestinal bacterial overgrowth. J Clin Endocrinol Metab. 2007;92: 4180–4
33. Zhou L, Li X, Ahmed A, Wu D, Liu L, Qiu J, et al. Gut microbe analysis between hyperthyroid and healthy individuals. Curr Microbiol. 2014;69:675–80.